Investors in the marijuana market have gained an abundance of cannabis listings to invest in. While Canada remains the hotbed of the cannabis investing world, the American market is seeing a rush for US cannabis stocks.
The market offers a variety of US cannabis stocks operating either directly in a legal market or seeing by gaining benefit from an investment or partnership.
Despite its nebulous status at the federal level, cannabis has flourished in the US as investors have gained entry into the country. Companies largely act as multi-state operators (MSOs), owning assets in states where the drug is legal.
For those interested in cannabis investment, the Investing News Network offers a look at a variety of publicly traded US cannabis stocks on American exchanges. The list includes US cannabis stocks operating in the industry or involved through an investment divided by the respective exchange.
This list includes stocks currently actively trading and involved in the marijuana industry available on US exchanges.
New York Stock Exchange
One of the premier listings in the public markets, the companies in this list represent a mix of pure cannabis plays that have reached a high enough level to be listed and established companies that gained exposure to the marijuana market one way or another. Due to the federal restrictions on cannabis, the companies in this list can’t directly be involved with the marijuana market in the US by way of touching the cannabis plant itself.
22nd Century Group (NYSEAMERICAN:XXII)
This biotech company is working on the development of genetically modified cannabis plants thanks to a sublicense agreement with Anandia Laboratories, an Aurora Cannabis (NYSE:ACB,TSX:ACB) subsidiary.
Altria Group (NYSE:MO)
As one of the largest tobacco companies, Altria Group manages a portfolio of assets across the globe. The company secured its stake in the marijuana industry with an investment deal signed with Cronos Group (NASDAQ:CRON,TSX:CRON).
Anheuser Busch InBev (NYSE:BUD)
This beverage maker secured an entry to the cannabis space thanks to a partnership to develop marijuana-infused drinks with Tilray (NASDAQ:TLRY).
Aphria was one of the first companies to reach the TSX and help solidify the growth of the marijuana industry. After undergoing a management change, the firm has maintained its attention to its scale growing operations and its international ventures.
Aurora Cannabis (NYSE:ACB,TSX:ACB)
Aurora Cannabis has secured a spot amid the leading producers of marijuana in Canada and has operations across the globe. The company has continued a steady path of acquisitions for players involved in all parts of the supply chain and development of marijuana technology.
CannTrust Holdings (NYSE:CTST,TSX:TRST)
CannTrust is a Canadian producer with a deep network of patient users that is actively developing its recreational offerings in the Canadian market. The company plans to develop hemp operations in the US market.
Canopy Growth (NYSE:CGC,TSX:WEED)
Canopy Growth is one of the largest leading Canadian cannabis producers, with investments across the entire sector. The firm has a significant investment from alcohol maker Constellation Brands (NYSE:STZ).
Constellation Brands (NYSE:STZ)
The beverage maker behind Corona beer has a play in the cannabis market thanks to its investment and ownership stake in Canopy Growth.
Similar to other marijuana-producing peers in the space, HEXO was able to secure a partnership with an established beverage maker to develop cannabis-infused drinks, thanks to a joint venture with Molson Coors Brewing Company (NYSE:TAP).
Innovative Industrial Properties (IIP) (NYSE:IIPR)
IIP is a real estate investment trust (REIT) signing lease deals for the use of facilities in the medical cannabis space. As a REIT, the company operates in the cannabis space but does not touch the cannabis plant in any way.
Molson Coors Brewing Company (NYSE:TAP)
Molson Coors Brewing Company is another beverage maker that gained an entry to the cannabis market through a partnership. The firm will aid in the development of cannabis-infused drinks for the legal Canadian market as part of its joint venture with HEXO.
Scotts Miracle-Gro Company (NYSE:SMG)
As one of the biggest consumer lawn and garden product sellers, this company has found a way to gain from the emergence of the cannabis market by offering services for the growing element of the industry without being directly involved with it.
The NASDAQ offers investors top-line companies with proven track records and performance. The mix of companies here also includes a few Canadian cannabis firms.
Cronos Group (NASDAQ:CRON,TSX:CRON)
Cronos is a leading marijuana firm with a blockbuster investment deal from Altria Group (NYSE:MO), one of the biggest tobacco producers in the world. The firm, like many other producers, has expressed interest in entering the US cannabis market at an appropriate time.
Organigram Holdings (NASDAQ:OGI,TSXV:OGI)
Organigram is an indoor grower of cannabis and supplier of the medical and recreational markets in Canada. Like other leading producers, the firm has plans for expansion on an international scale.
Neptune Wellness Solutions (NASDAQ:NEPT,TSX:NEPT)
Neptune is a company working in the extraction market alongside the marijuana space for novelty products. The firm also produces cannabis capsules using Licaps technology.
Tilray is one of the biggest cannabis companies in the world. As a producer, the firm manages assets in Canada where it offers medical and recreational products in the country. Tilray also holds international operations and has an established partnership with beverage maker Anheuser Busch InBev (NYSE:BUD).
Village Farms International (NASDAQ:VFF,TSX:VFF)
Village Farms is a vertically integrated greenhouse grower across North America. The company decided to enter the cannabis space through a 50/50 joint venture for the management of cannabis grower Pure Sunfarms.
OTCQX Best Market
This over the counter exchange is designed to offer listings to the most established companies looking to provide US investors with exposure into their markets.
1933 Industries (OTCQX:TGIFF,CSE:TGIF)
This vertically integrated company operates assets in both the Canadian and US cannabis markets including cultivation, extraction and production of hemp-derived items.
Abacus Health Products (OTCQX:ABAHF,CSE:ABCS)
This company develops over the counter topical medical items with hemp-derived CBD aimed at consumers looking for pain relief.
Acreage Holdings (OTCQX:ACRGF,CSE:ACRG.U)
Acreage Holdings is one of the largest multi-state operators of cannabis assets in the US market. This company secured an acquisition deal from Canopy Growth that will take effect once marijuana becomes legal in the US at a federal level.
Aleafia Health (OTCQX:ALEAF,TSX:ALEF)
Aleafia has a direct focus on the health and wellness space and its relationship with cannabis products.
AusCann Group Holdings (OTCQX:ACNNF,ASX:AC8)
AusCann is an Australian pharmaceutical firm participating in the medical cannabis market with cultivation operations and the development of cannabinoid-based pharmaceuticals.
Auxly Cannabis Group (OTCQX:CBWTF,TSXV:XLY)
Founded by Chuck Rifici, Tweed co-founder, Auxly operates as a cannabis streaming investment firm looking to boost various plays related to the sector.
Ayr Strategies (OTCQX:AYRSF,NEO:AYR.A)
Ayr operates as a vertically integrated MSO in the US cannabis sector, launching assets in Nevada and Massachusetts.
This Canadian cannabis company offers consumers a variety of recreational strains for sale in addition to oil products and products for medical patients.
CannaRoyalty/Origin House (OTCQX:ORHOF,CSE:OH)
This house of brands and California-based distributor of cannabis products earned an acquisition deal from Cresco Labs (OTCQX:CRLBF,CSE:CL) to reinforce its operations in the vibrant cannabis state market.
Cannex Capital Holdings (OTCQX:CNXXF,CSE:CNNX)
Cannex is an MSO with assets based in Washington and the states of Illinois, Maryland, Massachusetts and Pennsylvania through its proposed transaction with 4Front Holdings.
Canntab Therapeutics (OTCQX:CTABF,CSE:PILL)
This Ontario-based oral dosage formulation company researches and develops advanced pharmaceutical grade formulations of cannabinoids.
Captor Capital (OTCQX:CPTRF,CSE:CPTR)
Captor Capital is a vertically integrated cannabis investment company focused on the US marijuana market looking for exposure across the supply chain of this industry.
Cardiol Therapeutics (OTCQX:CRTPF,TSX:CRDL)
Cardiol is working on the development of medicines based on pharmaceutical grade cannabidiol (CBD) and refining the production of lab made elements of cannabis for medical use.
Citation Growth (OTCQX:CGOTF,CSE:CGRO)
This MSO holds a variety of brands under its portfolio and will pursue a market entry into Nevada.
Charlotte’s Web Holdings (OTCQX:CWBHF,TSX:CWEB)
This Colorado-based company operates as a hemp producer distributing novelty products in the legal US market.
Columbia Care (OTCQX:CCHWF)
Columbia Care is an MSO present in 15 jurisdictions in the US cannabis market, including marijuana shops and growing facilities.
Cresco Labs (OTCQX:CRLBF,CSE:CL)
One of the leading MSOs of the public space, Cresco Labs has gained the attention of investors and analysts thanks to its rapid expansion across legal state cannabis markets.
Curaleaf Holdings (OTCQX:CURLF,CSE:CURA)
Curaleaf is another leading MSO in the public markets operating a large portfolio of cannabis assets across the legal US state markets, including: Arizona, Connecticut, Florida, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York and Oregon.
Delta 9 Cannabis (OTCQX:VRNDF,TSXV:NINE)
This Manitoba-based Canadian cannabis producer has also established a retail presence in its home province. The firm has worked on partnerships to develop and use novel delivery methods of cannabis.
Dixie Brands (OTCQX:DXBRF,CSE:DIXI.U)
This company leverages the popularity of its brand appeal to offer cannabis products for the recreational market in the US.
Elixinol Global (OTCQX:ELLXF,ASX:EXL)
Elixinol is a producer of hemp-derived cannabidiol (CBD) oils for use in the medical cannabis market.
Emerald Health Therapeutics (OTCQX:EMHTF,TSXV:EMH)
This Canadian cannabis company holds a variety of growing assets in the country. The firm holds a 50/50 joint venture for the management of a grower in BC with Village Farms International (NASDAQ:VFF,TSX:VFF).
Eve & Co. (OTCQX:EEVVF,TSXV:EVE)
Eve & Co. is a Canadian cannabis producer that, thanks to its subsidiary Natural MedCo, is seeking to target women consumers specifically with premier brands.
Flower One Holdings (OTCQX:FLOOF,CSE:FONE)
Flower One Holdings is a cannabis company based in Nevada with full service cultivation operations all the way into processing and packaging. The company manages key retail brands to expand its business.
The Green Organic Dutchman (TGOD) (OTCQX:TGODF,TSX:TGOD)
After a successful capital raising, TGOD promises the benefits of organic cannabis production and cost effective operations. The company touts an international portfolio with operations in Europe and Latin America.
Green Thumb Industries (GTI) (OTCQX:GTBIF,CSE:GTII)
GTI is a Chicago-based MSO with cannabis operations across the US legal state markets, including its dispensary network.
Halo Labs (OTCQX:AGEEF,NEO:HALO)
This firm offers a play into the cannabis extraction market, as it produces cannabis oils and concentrates at its operations in California, Nevada and Oregon.
Harvest Health & Recreation (OTCQX:HRVSF,CSE:HARV)
This MSO operates a significant footprint across the US marijuana market through the management of cultivation and retail assets in legal state markets.
Harvest One Cannabis (OTCQX:HRVOF,TSXV:HVT)
Harvest One is a cannabis company with production and assets spread across Canada, Europe, Israel and Australia. The company gains its reach thanks to its three subsidiaries: United Greeneries, Satipharm and Dream Products.
Heritage Cannabis Holdings (OTCQX:HERTF,CSE:CANN)
This cannabis company has completed a variety of acquisitions to pursue its target of becoming a vertically integrated operator with cultivation, extraction and branding assets.
iAnthus Capital Holdings (OTCQX:ITHUF,CSE:IAN)
After successfully completing the acquisition of the US assets from a fellow cannabis company, iAnthus expanded its footprint as an MSO across the US.
INDIVA is a company focused on the supply of medical cannabis. Through an acquisition, this company holds a licensed producer with an indoor cannabis facility in Ontario.
Invictus MD (OTCQX:IVITF,TSXV:GENE)
This cannabis company with producing subsidiaries caught the attention of the market when it announced Gene Simmons of KISS fame as a chief evangelist and spokesperson for the company.
James E. Wagner Cultivation (OTCQX:JWCAF,TSXV:JWCA)
JWC is a premium cannabis brand company with a licensed producer as a subsidiary. The company differentiates itself as it grows cannabis through a proprietary aeroponic platform named Growthstorm.
KushCo Holdings (OTCQX:KSHB)
KushCo is a cannabis ancillary play as it provides services for cannabis products across the market. Its subsidiaries offer packaging items, accessories, vaporizer products and even pure hydrocarbons.
Lexaria Bioscience (OTCQX:LXRP,CSE:LXX)
This biotechnology company employs its patented DehydraTECH technology as the basis for its platform offerings TurboCBD, a high-absorption, full-spectrum hemp oil capsule, and ChrgD+, a water-soluble and ready-mix hemp supplement powder packet.
Liberty Health Sciences (OTCQX:LHSIF,CSE:LHS)
Created as a subsidiary of Aphria (NYSE:APHA,TSX:APHA), this firm was released as its own operating MSO model and has assets in Florida.
Lifestyle Delivery Systems (OTCQX:LDSYF,CSE:LDS)
This California-based cannabis company develops infused strip products sold through the medical and recreational markets.
Maple Leaf Green World (OTCQX:MGWFF,NEO:MGW)
Maple Leaf is a cannabis company with interests in the Canadian and US markets. The firm has growing operations in Canada with a focus on production and export of cannabis oil.
MediPharm Labs (OTCQX:MEDIF,TSXV:LABS)
MediPharm is a cannabis extraction company working on offering pharma-grade cannabis oils and concentrates to be used for infused products. The firm expects to process 250,000 kilograms of dry cannabis per year for extraction.
MedMen Enterprises (OTCQX:MMNFF,CSE:MMEN)
MedMen is an MSO that has been able to gain the attention of the California market thanks to its dispensaries and popular marketing. The firm has operations across the US and wants to expand the reach of its brand.
MJardin Group (OTCQX:MJARF,CSE:MJAR)
MJardin is a cannabis management platform company operating over 30 cannabis operations.
Next Green Wave Holdings (OTCQX:NXGWF,CSE:NGW)
Next Green Wave is a vertically integrated cannabis company with producing assets and a portfolio of brands in California.
Phivida Holdings (OTCQX:PHVAF,CSE:VIDA)
This company has operations in Canada and the US to support its health and wellness business of premium organic hemp-based food and beverage products.
Planet 13 Holdings (OTCQX:PLNHF,CSE:PLTH)
This cannabis company has a specific focus on the Nevada market with cultivation and retail assets. The firm manages a mega-store dispensary in Las Vegas, and plans to develop another shop in California.
Plus Products (OTCQX:PLPRF,CSE:PLUS)
Plus Products specializes in the production and development of branded edible products sold in the California market.
Radient Technologies (OTCQX:RDDTF,TSXV:RTI)
Radient is an extraction technology company that has dabbled in the cannabis sector thanks to a partnership with licensed producer Aurora Cannabis (NYSE:ACB,TSX:ACB).
Rubicon Organics (OTCQX:ROMJF,CSE:ROMJ)
Rubicon Organics is a Canadian-based cannabis producer focussed on organic and premium growth out of its Delta, BC, facility. The company also participates in the US market with the management of two brand and a presence of assets in the Washington state marijuana space.
The Supreme Cannabis Company (OTCQX:SPRWF,TSX:FIRE)
Supreme Cannabis has earned a reputation as a dedicated producer with operations growing at a steady scale. This company has a focus on brand development and an interest in international plays for the cannabis market.
TerrAscend is a vertically integrated operator of cannabis assets in North America with investments in Canada and the US cannabis markets. The company has an investment partnership from Canopy Rivers (OTC Pink:CNPOF,TSXV:RIV).
Terra Tech (OTCQX:TRTC)
Terra Tech is a vertically integrated cannabis-focused agriculture company overseeing cultivation operations alongside its retail and recreational brands.
THC Biomed (OTCQB:THCBF,CSE:THC)
This cannabis company holds cultivation assets in Canada and works on the development of new scientific research for its medical products.
Tinley Beverage (OTCQX:TNYBF,CSE:TNY)
Tinley is a beverage company developing hemp-infused beverages and supplements for the US market.
True Leaf Brands (OTCQX:TRLFF,CSE:MJ)
This company develops natural hemp products designed for humans and pets.
Vapen MJ Ventures (OTCQX:VAPNF,CSE:VAPN)
Vapen MJ acts as an agricultural technology company overseeing a play in the cannabis market through the development of high margin products such as vape cartridges, concentrates and edibles.
VIVO Cannabis (OTCQX:VVCIF,TSXV:VIVO)
VIVO is an Ontario-based cannabis producer selling product to patients and appealing to higher-end recreational consumers in Canada through its proprietary premium brands.
WeedMD is another Canadian cannabis producer making product for the medical and recreational markets in Canada.
OTCQB Venture Market
The middle level for the over the counter exchanges. The OTCQB is a venture level exchange designed for companies at an early-stage of development looking to offer investors exposure into new markets.
3 Sixty Risk Solutions (OTCQB:SAYFF,CSE:SAFE)
This company is an ancillary play to the cannabis market as it specializes in security services and consultation for marijuana producers seeking to remain compliant and protected.
Affinor Growers (OTCQB:RSSFF,CSE:AFI)
This company offers agricultural technology to clients looking to improve their food growing businesses. As part of its cannabis operations, the firm offers specialized lights for the growing of marijuana.
Agrios Global Holdings (OTCQB:AGGHF,CSE:AGRO)
Agrios is a specialized company in Washington state offering data analytics driven agricultural technology and other services to the cannabis industry, such as property and equipment leases.
Alliance Growers (OTCQB:ALGWF,CSE:ACG)
This medical cannabis company utilizes a four pillar structure: cannabis biotech complex, strategic licensed producer investments, CBD oil supply and distribution, and research and technology to guide its operations.
Alternate Health (OTCQB:AHGIF,CSE:AHG)
This technology company offers particular services to the marijuana industry, including specialty medical cannabis software.
Australis Capital (OTCQB:AUSAF,CSE:AUSA)
A spin off from Aurora Cannabis (NYSE:ACB,TSX:ACB), this firm is designed to provide investments in the overall cannabis market, including operations in the US and internationally.
Avricore Health (OTCQB:AVCRF,TSXV:AVCR)
While Avricore operates as a healthcare technology company, in 2017 the firm made a deal with Emerald Health Therapeutics (OTCQX:EMHTF,TSXV:EMH) for the right to develop and sell endocannabinoid products in Canada to licensed pharmacies.
Belgravia Capital International (OTCQB:BLGVF,CSE:BLGV)
This ancillary company to the marijuana industry offers a variety of adjacent services to the growing of cannabis and a platform of product tracking using blockchain technology.
Biome Grow (OTCQB:BIOIF,CSE:BIO)
Thanks to its subsidiaries, this company has a cultivation to distribution business model with its cannabis operations in Atlantic Canada.
Blueberries Medical (OTCQB:BBRRF,CSE:BBM)
This international cannabis company is a producer in Latin America with licensed operations in Colombia and new assets in Argentina.
CannAmerica Brands (OTCQB:CNNXF,CSE:CANA)
This company uses the brands in its portfolio to offer consumers specialty products. CannAmerica has operations in Colorado, Nevada and Maryland.
Cannara Biotech (OTCQB:LOVFF,CSE:LOVE)
This company operates in Canada and the US thanks to its operations in Quebec and the start of branded hemp-derived CBD products.
CB2 Insights (OTCQB:CBIIF,CSE:CBII)
This company employs clinical management and data collection software solutions for the marijuana industry.
Chemesis International (OTCQB:CADMF,CSE:CSI)
Chemesis is a vertically integrated cannabis company with operations in Puerto Rico and California.
Chemistree Technology (OTCQB:CHMJF,CSE:CHM)
This cannabis investment company looks for exposure into the US cannabis market and seeking to offer turn-key solutions for the legal industry.
Choom Holdings (OTCQB:CHOOF,CSE:CHOO)
Choom is a retail operator of marijuana dispensaries in Canada looking to leverage its expertise with new stores in North America.
This Canadian cannabis company offers services and investment to the processing markets of the marijuana space.
DionyMed Brands (OTCQB:DYMEF,CSE:DYME)
This company acts as a vertically integrated firm developing its portfolio of branded cannabis products with operations in California and Oregon.
Experion Holdings (OTCQB:EXPFF,TSXV:EXP)
Formerly known as Viridium Pacific Group, this cannabis investment firm holds a portfolio of assets, including its licensed producer Experion Biotechnologies in Mission, BC.
FinCanna Capital (OTCQB:FNNZF,CSE:CALI)
FinCanna is a royalty finance company evaluating the cannabis market in the US, with a direct interest in California. The company offers access to capital for companies as part of a royalty payment methodology.
FluroTech is a technology company working on a cost-effective testing platform for the cannabis industry at large. The company’s proprietary CompleTest employs fluorescence spectroscopy technology to measure the specific contents of the product.
FSD Pharma (OTCQB:FSDDF,CSE:HUGE)
FSD Pharma is a cannabis company that is evaluating research and development for cannabinoid treatments for serious diseases. The subsidiary of the company holds a cultivation license in Canada.
Future Farm Technologies (OTCQB:FFRMF,CSE:FFT)
Future Farm Technologies is an ancillary play to the cannabis market thanks to its specialized LED lighting systems for growers and other indoor growing solutions.
Gabriella’s Kitchen (OTCQB:GABLF,CSE:GABY)
Gabriella’s Kitchen is a pure-play health and wellness company looking to sell CBD infused products to consumers in the mainstream grocery environment.
Global Cannabis Application (OTCQB:FUAPF,CSE:APP)
The company seeks patients looking for more advanced cannabis-based medicines through its Citizen Green Technology Platform, which aims for candidates for clinical studies.
Golden Leaf Holdings (OTCQB:GLDFF,CSE:GLH)
Golden Leaf Holdings is a cannabis oil and solutions provider in North America with operations in Oregon, Nevada and Canada.
Green Growth Brands (GGB) (OTCQB:GGBXF,CSE:GGB)
GGB is a cannabis company offering consumers with marijuana and CBD branded products. The company differentiates itself thanks to the experience from its management team, which includes former executives for brands such as American Eagle Outfitters (NYSE:AEO).
GTEC Holdings (OTCQB:GGTTF,TSXV:GETC)
This Kelowna-based cannabis company is vertically integrated, with operations in the cultivation, extraction and analytical testing sectors. The company is also pursuing retail operations through various investments.
This marijuana company operates on two different fronts as it develops modern accessories for consumers and it also manages a line of retail shops across Canada.
Integrated Cannabis Company (OTCQB:ICNAF,CSE:ICAN)
This company works on the development and advancement of delivery systems and formulations.
Isodiol International (OTCQB:ISOLF,CSE:ISOL)
Isodiol has adjusted its focus to the emerging hemp market in the US through the development of branded consumer products.
Kalytera Therapeutics (OTCQB:KALTF,TSXV:KLY)
This is a pharmaceutical company working on the development of CBD-based therapeutics for disease treatment.
Khiron Life Sciences (OTCQB:KHRNF,TSXV:KHRN)
Khiron is a Colombia-based cannabis company. The firm has declared that it will seek to expand its presence through Latin America, including Mexico.
Leviathan Cannabis (OTCQB:LVCNF,CSE:EPIC)
A marketing and consumer engagement company offering its services to the North American marijuana industry.
LGC Capital (OTCQB:LGGCF,TSXV:LG)
LGC Capital is a cannabis investment firm looking for opportunities across the market on a global scale. The firm has investments in Canada, Jamaica, Australia and some regions in Europe.
Liberty Leaf Holdings (OTCQB:LIBFF,CSE:LIB)
Liberty Leaf is a Canadian company looking to expand its portfolio of cannabis businesses, which include: growing, processing and distribution of CBD products as well as accessories.
Lift & Co. (OTCQB:LFCOF,TSXV:LIFT)
Lift is well known for its cannabis conferences in Canada. In addition to its shows, the company offers consumers an online hub for information, reviews and commentary on the marijuana space. The company also developed a training program for cannabis retailers in Canada.
Matica Enterprises (OTCQB:MMJFF,CSE:MMJ)
Thanks to its subsidiary, this firm cultivates cannabis in Quebec with plans for further expansion. The company is also pursuing alternative delivery methods of cannabis such as topical products.
MYM Nutraceuticals (OTCQB:MYMMF,CSE:MYM)
MYM is a cannabis grower with operations in Canada looking at the distribution of its products at the global landscape.
Namaste Technologies (OTCQB:NXTTF,TSXV:N)
After undergoing a tumultuous management change, Namaste has centered back on its investments and development of its marijuana play, which includes its online platform of cannabis consumer information.
Naturally Splendid Enterprises (OTCQB:NSPDF,TSXV:NSP)
Naturally Splendid is a biotech company working on the development of hemp products for consumers in the health and wellness space. The company will pursue a stake in the edible CBD market as well.
NexTech AR Solutions (OTCQB:NEXCF,CSE:NTAR)
NexTech is a company engaged in the development of augmented reality (AR) services to various industries, including the marijuana market through web-enabled AR platform with artificial intelligence and analytics.
North Bud Farms (OTCQB:NOBDF,CSE:NBUD)
North Bud Farms, an early-stage cannabis company, is pursuing a license in Canada through its subsidiary GrowPros for a facility in Quebec.
Nutritional High International (OTCQB:SPLIF,CSE:EAT)
This marijuana company is focused on the development of edible products and oil extracts for the US medical and recreational markets.
Orion Nutraceuticals (OTCQB:ORONF,CSE:ORI)
Orion Nutraceuticals operates cultivation assets in Colombia, growing CBD strains for medical use through innovative products.
Pivot Pharmaceuticals (OTCQB:PVOTF,CSE:PVOT)
Pivot Pharmaceuticals, a biopharmaceutical company, has a subsidiary exploring the research of cannabinoid-based nutraceuticals and pharmaceutical items.
Premier Health Group (OTCQB:PHGRF,CSE:PHGI)
Premier Health Group is a company working on a global health care strategy. Additionally, thanks to a partnership with CB2 Insights, the company has a data-driven program to aid with patient evaluations for medical cannabis use.
Preveceutical Medical (OTCQB:PRVCF,CSE:PREV)
This health sciences manufacturer of therapies announced the creation of a cannabis division set to work on the development and eventual introduction of medicinal cannabis-based products to the market.
RavenQuest BioMed (OTCQB:RVVQF,CSE:RQB)
RavenQuest BioMed is a cannabis company with technology and cultivation assets that has facilities in Alberta and Ontario.
Redfund Capital (OTCQB:PNNRF,CSE:LOAN)
This merchant bank offers debt instruments and equity investing to cannabis companies with a solid track record of revenue.
Relevium Technologies (OTCQB:RLLVF,TSXV:RLV)
Thanks to its subsidiary Biocannabix, this company has a cannabis play in the development of pharmaceutical grade products infused with cannabinoid formulations.
Revive Therapeutics (OTCQB:RVVTF,TSXV:RVV)
This biotech company gains exposure to the marijuana space thanks to its research and development of CBD-based wellness products.
Sproutly Canada (OTCQB:SRUTF,CSE:SPR)
Sproutly is a cannabis company working on the development of cannabis-infused drinks thanks to its proprietary technology and a joint venture partnership with Moosehead Breweries.
Stem Holdings (OTCQB:STMH,CSE:STEM)
Stem Holdings is a vertically integrated cannabis company with assets in Nevada, Oklahoma and Oregon. The firm oversees a variety of brands in the US market.
Sunniva is a vertically integrated cannabis company with operations across the border both in Canada and the US.
Tetra Bio-Pharma (OTCQB:TBPMF,TSXV:TBP)
Tetra Bio-Pharma is a company working on the research and development of medicines based on cannabis and its elements.
THC Biomed (OTCQB:THCBF,CSE:THC)
This cannabis company holds cultivation assets in Canada and works on the development of new scientific research for its medical products.
Theramed Health Corporation (OTCQB:EVAHF,CSE:TMED)
This medical technology company gains a play in the marijuana sector thanks to specialized systems designed to monitor CBD consumption and effects in patients.
TILT Holdings (OTCQB:SVVTF,CSE:TILT)
TILT Holdings is a vertically integrated technology company offering business to the cannabis industry through its software platform.
Tree of Knowledge International (OTCQB:TOKIF,CSE:TOKI)
Tree of Knowledge International is a diversified company based in Toronto. It is working on the treatment of chronic pain through cannabis, the production of formulated natural products and the distribution of hemp-based CBD items.
Valens GroWorks (OTCQB:VGWCF,TSXV:VGW)
Valens is a firm capitalizing on the ancillary market of cannabis extraction. As the demand for refined extracts continues, Valens offers extraction services capable of managing 425,000 kilograms of dried cannabis and hemp.
Weekend Unlimited (OTCQB:WKULF,CSE:POT)
This company offers investors a diversifying portfolio of cannabis brands in markets such as California, Washington state, British Columbia and Las Vegas. It has a specific focus on dried flower, edibles and extracts products.
Wildflower Brands (OTCQB:WLDFF,CSE:SUN)
This house of brands company seeks to develop new branded products in the health and wellness market across the US. The firm also has a presence in Poland and Canada.
Yield Growth (OTCQB:BOSQF,CSE:BOSS)
Yield Growth is a company appealing to premium cannabis and hemp consumers through its high end brands Urban Juve and Wright & Well.
Zelda Therapeutics (OTCQB:ZLDAF,ASX:ZLD)
Zelda Therapeutics is an Australian pharmaceutical company working on the development of cannabinoid-based treatments.
OTC Pink Open Market
The OTC Pink Open Market offers a diverse array of options for investors. However, this exchange does not have the same requirements as its fellow over the counter siblings and therefore is more risky.
AgraFlora Organics International (OTC Pink:PUFXF,CSE:AGRA)
This vertically integrated cannabis company oversees cultivation assets in Canada for its production and also operates a variety of brands in various aspects of the market.
Alcanna (OTC Pink:LQSIF,TSX:CLIQ)
Alcanna is an alcohol retail operator first and foremost, but thanks to an investment from Aurora Cannabis (NYSE:ACB,TSX:ACB), the company now also manages marijuana retail shops across the country under the retail brand name Nova Cannabis.
This technology company offers services to the cannabis market through its CannaBlox blockchain-based technology service for seed-to-sale tracking, done in partnership with Liberty Leaf Holdings (OTCQB:LIBFF,CSE:LIB).
Body and Mind (OTC Pink:BMMJ,CSE:BAMM)
Thanks to its Nevada-based subsidiary, the company grows marijuana for its brand of products such as dried flower, oil extracts and edible items.
C21 Investments (OTC Pink:CXXIF,CSE:CXXI)
C21 is a vertically integrated cannabis company with a direct focus on the US market thanks to its operations in Oregon.
Cannabix Technologies (OTC Pink:BLOZF,CSE:BLO)
This technology company is actively developing breath testing devices that offer guaranteed detection of marijuana use in impaired drivers.
Canopy Rivers (OTC Pink:CNPOF,TSXV:RIV)
Canopy Rivers is the investment arm of Canopy Growth (NYSE:CGC,TSX:WEED), and it acts as its own operating company. This firm explores investments in the cannabis market and ancillary plays that can benefit from the thriving space.
CannaOne Technologies (OTC Pink:CNONF,CSE:CNNA)
This cannabis technology company offers clients the BloomKit, a business-to-business software platform designed to offer high functionality for retail or online operations.
Cannvas MedTech (OTC Pink:CANVF,CSE:MTEC)
This education-based technology company offers its clients customer-centric solutions for the enhancement of data use to better understand consumers and the industry as a whole.
City View Green Holdings (OTC Pink:LRZZF,CSE:CVGR)
This early-stage cannabis company seeks to operate a growth, extraction, production and retail business cycle model with vertical integration.
CROP Infrastructure (OTC Pink:CRXPF,CSE:CROP)
This company offers licensed cannabis producers capital set to be used for operations related to the use of land, infrastructure of operations and branding. The firm also has its own operations and branded products in the US.
Empower Clinics (OTC Pink:EPWCF,CSE:CBDT)
Empower Clinics oversees the management of a growing network of medical cannabis clinics in the US.
EnWave (OTC Pink:NWVCF,TSXV:ENW)
EnWave is a technology company that has centered itself in the cannabis business thanks to its Radiant Energy Vacuum drying technology for organic materials. It effectively decreases the time from the harvest to the sale of cannabis products.
The Flowr Corporation (OTC Pink:FLWPF,TSXV:FLWR)
Flowr is a vertically integrated cannabis company working on cultivation and sale of medical and recreational marijuana in Canada.
Global Hemp Group (OTC Pink:GBHPF,CSE:GHG)
Global Hemp Group will seek a market share in the industrial hemp market in North America through a two-stage phase development.
Grown Rogue International (OTC Pink:GRUSF,CSE:GRIN)
Grown Rogue is a cannabis company in the US with critical assets in California, Oregon and Michigan offering branded marijuana products.
ICC International Cannabis (OTC Pink:WLDCF,CSE:WRLD.U)
ICC is an international marijuana firm seeking to gain partners and subsidiaries across the globe to design and build quality low-cost producing cannabis facilities.
Koios Beverage (OTC Pink:KBEVF,CSE:KBEV)
This beverage company owns a subsidiary developing drink formulations of CBD-infused items.
Micron Waste Technologies (OTC Pink:MICWF,CSE:MWM)
This ancillary company offers a solution to organic waste generated from marijuana cultivation through on-site treatment system technologies.
Mojave Jane Brands (OTC Pink:HHPHF,CSE:JANE)
This Canadian cannabis company has operations in the US cannabis market through the management of its distribution subsidiary in the California cannabis industry.
Nextleaf Solutions (OTC Pink:OILFF,CSE:OILS)
Nextleaf Solutions is a cannabis extraction and technology company looking to license its methodologies as it offers an industrial-scale process of producing purified cannabinoid distillate.
Orchid Ventures (OTC Pink:ORVRF,CSE:ORCD)
This company develops and sells vaporizers in California and Nevada through a B2B and wholesale business model. It seeks to expand its presence in the US market.
Organic Flower Investments (OTC Pink:QILFF,CSE:SOW)
This is an investment company seeking to provide early-stage financing to companies, including those in the medical and recreational cannabis markets.
Pasha Brands (OTC Pink:CRFTF,CSE:CRFT)
This vertically integrated house of brands company has subsidiary cultivation operations in BC.
Pharmacielo (OTC Pink:PHCEF,TSXV:PCLO)
Pharmacielo is another cannabis company originally from Colombia raising capital in the Canadian markets. The company is headquartered in Canada but operates as part of its marijuana growing in Rionegro, Colombia.
Rockshield Capital (OTC Pink:RKSCF,CSE:RKS)
This is an early stage venture capital fund and merchant bank company that has added some cannabis interests to its portfolio, including The Green Organic Dutchman (OTCQX:TGODF,TSX:TGOD), Emblem and Halo Labs (OTCQX:AGEEF,NEO:HALO).
SOL Global Investments (OTC Pink:SOLCF,CSE:SOL)
This cannabis investment company leverages its holdings across the cannabis industry but has a direct focus on the US market.
Stillcanna (OTC Pink:SCNNF,CSE:STIL)
This Canadian company has a clear focus on the European market through large scale CBD extraction business offerings.
Trulieve Cannabis (OTC Pink:TCNNF,CSE:TRUL)
Trulieve Cannabis is an MSO based in Florida with a leading position in the sunshine state. The firm has expressed interest in expanding, with acquisitions in California and Massachusetts.
TruTrace Technologies (OTC Pink:TTTSF,CSE:TTT)
TruTrace incorporates a software aspect into the cannabis market by bringing its blockchain-based program that tracks cannabis intellectual property all across the sale chain.
Ventura Cannabis and Wellness (OTC Pink:CVHIF,CSE:VCAN)
This vertically integrated company is based in the vibrant California market and has plans to pursue the cannabis and CBD product selling market.
Veritas Pharma (OTC Pink:VRTHF,CSE:VRT)
Veritas Pharma is a company conducting research for medicinal cannabis therapies, products and services.
Want more details? Check out these articles for more INNdepth coverage.
- The Reason Cannabis Investors Should Be Watching Tilray
- Are US Marijuana Stocks a Good Buy?
- States to Follow for US Cannabis Investments
- What You Need to Know About the Florida Cannabis Market
- Cannabis Investment: Canadian Cannabis Stocks
Want an overview of investing in cannabis stocks? Check Investing in the Cannabis Industry
Are there any US cannabis stocks you think should be on this list? Let us know in the comments — we’ll be updating it in the future. And don’t forget to follow us @INN_Cannabis for real-time news updates!
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: 1933 Industries, Acreage Holdings, Cannex Capital Holdings, Cardiol Therapeutics, Captor Capital, Flower One Holdings, Harvest One Cannabis, Heritage Cannabis Holdings, Invictus MD, Lexaria Bioscience, MediPharm Labs, Next Green Wave Holdings, Alliance Growers, Avricore Health, Cannara Biotech, CB2 Insights, Chemesis International, Chemistree Technology, FinCanna Capital, FluroTech, Green Growth Brands, GTEC Holdings, High Tide, Kalytera Therapeutics, Chiron Life Sciences, Matica Enterprises, MYM Nutraceuticals, Naturally Splendid Enterprises, Nutritional High International, Preveceuticals Medical, Redfund Capital, Relevium Technologies, Valens GroWorks, Weekend Unlimited, Wildflower Brands, Yield Growth, Blox Labs, Cannvas MedTech, CROP Infrastructure, The Flower Corporation, Grown Rogue International, Mojave Jane Brands, Nextleaf Solutions, Orchid Ventures, are clients of the Investing News Network. This article is not paid-for content.
Click here to read the previous cannabis update.
During the first few months of investment time in 2021, cannabis faced some volatility alongside optimism about federal changes in the most important market for the drug.
The cannabis business found its stride during Q1 thanks to policy change signals and consolidation.
To find out more, the Investing News Network (INN) asked experts about progress in the market during the first major period of the new year, and which developments investors should watch out for.
Cannabis market update: New York and US potential boost operations
New York state’s legalization of recreational cannabis was a huge Q1 announcement that added pressure to the federal government when it comes to cannabis policy, said George Mancheril, co-founder and CEO of Bespoke Financial, a debt financing business with a particular focus on servicing cannabis businesses.
“It’s going to add to the chorus of voices in the federal scene to basically move sooner rather than later,” he explained to INN.
Following the US election in 2020, the momentum for cannabis businesses went on the upswing, as did company valuations, with the idea of expansion at the heart of it all, according to Mancheril.
Before starting Bespoke Financial, Mancheril learned from traditional investment banks, where he worked on lending, fixed income and debt markets with Goldman Sachs (NYSE:GS) and Guggenheim Partners.
Nawan Butt, portfolio manager with Purpose Investments, agrees with Mancheril. The financial expert told INN the ongoing legalization process seen in the US market is leading to expansion.
“It’s becoming more of a national move, then small pockets of proliferation. That’s very exciting about cannabis right now,” said Butt, who co-manages the Purpose Marijuana Opportunities Fund (NEO:MJJ).
This proliferation effect is causing a change in valuations and enthusiasm for US-based operations. Mancheril told INN that by the end of Q1, multi-state operators (MSOs) had raised approximately US$3.3 billion.
The cannabis lender said he sees the industry as having grown from the woes of 2019; it is now seeing a return to form by way of the excitement for an ongoing opening process in the US.
The expert explained that there is likely to be a windfall of capital in the wake of major federal changes for cannabis policy, although the timeline for these changes is becoming increasingly hard to predict.
Leading up to that capital influx, Mancheril said he wants to see operators really drill down on the value of desired assets and whether they make sense.
“What I’d hope is that we continue to see bullish sentiment, but with some measure of responsibility, and let’s not just get over ahead of ourselves,” Mancheril told INN. “The idea is let’s minimize the volatility and continue growing responsibly.”
As far as struggles go, Butt explained that the cannabis industry has cemented itself as a growth-type sector, and as such there are macro environment pressures affecting the way these assets operate.
“We’ve seen this preference for cash flows at growth in the current or in the near future, rather than in the far future, and that’s what we’re seeing as far as valuations go in the broad market,” Butt said.
Cannabis market update: Volatility continues to rule as industry foundations build
Despite the industry’s current potential and the growing pains it has gone through as a whole in both the US and Canada, volatility remains a key factor in the cannabis investment scene.
Butt explained that the current shareholder base, which is dominated by hedge funds and retail investors, still lacks enough institutional support to avoid the day-to-day volatility cannabis has come to be known for.
These two investor groups, Butt said, can be easily spooked and excited by the news of the day when it comes to their investments.
“A lot of these institutions’ strategies are not about short-term profits, but they’re about long-term sustainability of the businesses themselves,” Butt said.
“That’s why you see a lot of volatility in the space, and that’s essentially what we’ve seen over the past, I’d say, three to two months as well,” he added.
That means investors shouldn’t expect an end to volatility anytime soon.
“It’s not about whether we continue to expect volatility, because we do,” Butt said. “We really think that the volatility will be taken out when the shareholder base becomes more institutional, but it’s really about understanding why there is volatility in the first place.”
Cannabis market update: Canadians talk up US business potential, but questions remain
A surge of mergers and acquisitions has taken over the Canadian cannabis sector recently as more producers see potential in America.
Using the funds, the two will work in tandem to develop new branded products designed to work on the international stage, including in the US. Organigram CEO Greg Engel previously told INN that the US represents a critical opportunity for Canadian companies, but the entry point isn’t as clean as it could be at the moment.
While the long-term potential may be exciting for investors, Butt told INN he’s still unsure how the approach will work for Canadian companies.
The Purpose Investments expert said there will be plenty of space for the biggest Canadian names to pursue US market entries, beyond the initial hemp-derived CBD moves some operators have mde, since the US represents the biggest market in the world.
“But there’s just way too many unknowns right now to say exactly what that participation is going to look like, or when that participation will happen,” he said.
“What we do know is that currently the US MSOs are in a wonderful sort of position to expand on their market leadership that they have. And it will be tough for Canadians to come in and compete with them,” Butt said.
Canadian players still retain the upper hand at times in terms of valuation, which is confusing for both Butt and Dan Ahrens, chief operating officer and portfolio manager at AdvisorShares.
“The performance in quarterly earnings of US companies has been rather spectacular. They’ve knocked it out of the park in most instances,” Ahrens told INN.
Butt praised the recent performance reports from MSOs across the board, pointing to year-over-year growth lines and projections for continued positive performance.
In his view, share prices still don’t reflect company value. “Those are really being discounted at this point,” Butt told INN.
“We’ve seen the Canadian licensed producers be really hot stock performance-wise, outpacing the US (MSOs), and I’ll say it’s rather nonsensical to me,” said Ahrens, who oversees the AdvisorShares Pure Cannabis ETF (ARCA:YOLO) and the recently launched AdvisorShares Pure US Cannabis ETF (ARCA:MSOS).
Cannabis market update: Investor takeaway
The cannabis investment proposition finds itself at an interesting moment in time, as the entire sector eagerly awaits confirmation in the US at the federal level.
While for the Canadians waiting on the sidelines, this development may feel like a major necessity to address current financial struggles, for US-based operators, the heat around the corner could represent an increase to their already thriving operations.
Want more details? Check out these articles for more INNdepth coverage:
- Cannabis Investment: Canadian Cannabis Stocks
- Invest in Cannabis: TSX Cannabis Stocks
- Cannabis Companies: Stocks on the TSXV
- CSE Marijuana Stocks
Want an overview of investing in cannabis stocks? Check out Investing in the Cannabis Industry.
Trulieve Cannabis Corp. Announces Release Date, Conference Call and Webcast for the First Quarter of 2021
Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its first quarter 2021 financial results on Thursday, May 13, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.
All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 4880609. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until May 20, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 4880609.
A live audio webcast of the conference call will be available at: https://produceredition.webcasts.com/starthere.jsp?ei=1456168&tp_key=12329b312c
Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to join the webcast. An archived replay of the webcast will be available for 90 days by clicking the link above.
Trulieve is primarily a vertically integrated “seed-to-sale” company in the U.S. and is the first and largest fully licensed medical cannabis company in the State of Florida . Trulieve cultivates and produces all of its products in-house and distributes those products to Trulieve-branded dispensaries throughout the State of Florida , as well as directly to patients via home delivery. Trulieve is also a licensed operator in California , Massachusetts , Connecticut , Pennsylvania , and West Virginia . Trulieve is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX Best Market under the symbol TCNNF.
To learn more about Trulieve, visit www.Trulieve.com .
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
SOURCE Trulieve Cannabis Corp.
News Provided by PR Newswire via QuoteMedia
Avicanna Announces Initial Listings and Sales for Evidence-Based RHO Phyto Products in Canada’s Adult Use Channels Including Ontario, Manitoba, Saskatchewan, and New Brunswick
- Expanding from the successful nation-wide launch in medical-only channels through Medical Cannabis by Shoppers Drug Mart™ the company set out to rapidly commercialize its RHO Phyto products through retail channels and has succeeded in doing so within a three-month period.
- In collaboration with Velvet’s sale infrastructure, the RHO Phyto products which include its advanced formulary of sublingual sprays, oil drops and topicals, are launching into retail sales channels valued at $2.6 billion in 20201 in Canada.
- The initial listings across four provinces and start of retail channel sales validate market demand for the growing segment in Avicanna’s advanced medical and wellness products within the retail channels.
Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products is pleased to announce the listing of certain RHO Phyto products with the Ontario, Manitoba, Saskatchewan and New Brunswick provincial retailers (the “Initial Listing”).
Establishing a Leadership Position Within the Medical Community and Patients
Since its launch in Medical Cannabis by Shoppers Drug Mart™ in Q3 2020, the RHO Phyto product line has experienced incredible success with overwhelming positive support from the medical community including 500+ prescribers and 30 medical cannabis clinics. RHO Phyto sales have increased over 40% month over month in all product categories and have successfully segmented and targeted medical and wellness consumers. Nearly 90% of the consumers of the RHO Phyto oral products including sublingual sprays and oral drops are over the age of 31 and 52% are female.
Avicanna will remain exclusive to Medical Cannabis by Shoppers Drug Mart for medical-only channels and has increased its current commercial offering from 2 to 7 SKU’s in response to high demand from patients.
Successful Expansion into Retail Channels Provides a Low Barrier to Consumers Accessing the Industry’s Leading Formulary of Medical and Wellness Products.
It has become evident that many consumers who seek cannabis for medical and wellness purposes are not necessarily going through medical channels, with nearly 44% purchasing from adult use channels2. According to the 2020 Canadian Cannabis Survey, 76% of medical cannabis users do not have a medical document from a healthcare practitioner3. The systemic barriers to connecting with health care professionals, ease of access to storefronts and e-commerce channels, and expansion of the wellness category product offerings have all contributed to the increase in consumer demand for cannabinoid based medical and wellness products across adult use channels.
Within a short 3-month time frame, the Company has successfully established its production infrastructure, expanded the RHO Phyto product portfolio, and obtained the Initial Listings from four Canadian provinces. RHO Phyto products have already been delivered to the provincial retailers, including Ontario which represents the largest Canadian market opportunity.
“The initial demand and provincial listings in such a saturated market is a fantastic validation of the differentiation and market acceptance of the RHO Phyto product line beyond the medical cannabis channels. The rapid execution by our team will allow us to capture market share in the evolving medical and wellness categories within the adult use channels and is expected to be a significant revenue driver for the company in 2021.” commented Aras Azadian, CEO of Avicanna.
The sales and distribution of RHO Phyto is completed in collaboration with Velvet Management Inc. which is a national sales and marketing agency with 100% focus on adult use cannabis. Velvet was created by the largest importer of alcohol in Canada, Groupe Dandurand, responsible for $1.2 billion in retail sales. Velvet Management Inc., with 40+ employees, has become one of largest sales and marketing agencies in Canada with offices in Montreal, Toronto, Calgary, and Vancouver.
RHO Phyto Product Attributes and Retail Sales Strategy
The advanced and standardized products are offered in various doses of CBD, THC and THC-Free formulations to provide consumers with a range of inhalation-free cannabinoid-based solutions. The advanced formulations are developed and optimized by Avicanna to provide enhanced absorption versus basic medium-chain triglyceride (MCT) oil formulations while providing a consistent experience with a pleasant taste and smell. The RHO Phyto products are delivered with accurate dosing which also allows for easy titration and dosing by consumers.
Avicanna’s RHO Phyto strategy to leverage retail sales channels is consistent with the Company’s vision to provide education and safe delivery of its products through evidence-based training and education to consumers, retailers and the medical community. Avicanna aims to establish RHO Phyto as a recommended brand within the cannabis industry and has initiated several pre-clinical and real-world evidence clinical trials on the products with leading Canadian medical institutions.
1 Statistics Canada. Table 20-10-0008-01 Retail trade sales by province and territory (x 1,000)
2 Health Canada. (2021). Canadian Cannabis Survey 2020 Survey.
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Avicanna is an established leader in cannabinoid research and development, with its research conducted primarily at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:
- Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
- RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GPP standards and supported by pre-clinical data.
With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposiums, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.
Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with its shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.
For more information about Avicanna, visit www.avicanna.com, call 1-647-243-5283, or contact Setu Purohit, President by email at email@example.com.
The company posts updates through videos from the official company YouTube channel https://www.youtube.com/channel/UC5yBclNIsNf7VrE34iwt8OA.
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the incredible success of the RHO Phyto product line, sales of the RHO Phyto products increasing month over month in all product categories, the Company’s ability to successfully segment and target medical and wellness consumers, the high demand for the RHO Phyto products, the increase in consumer demand for cannabinoid based medical and wellness products across adult use channels, the Company’s ability to maintain positive support of the RHO Phyto products from the medical community including 500+ prescribers and 30 medical cannabis clinics, the Company’s ability to continue to deliver RHO Phyto products to provincial retailers, the differentiation and market acceptance of the RHO Phyto product line, the Company’s ability to capture market share in the evolving medical and wellness categories within the adult use channels, the likelihood that RHO Phyto will be a significant revenue driver for the company in 2021, the ability of the Company to establish RHO Phyto as a recommended brand within the cannabis industry. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment, and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020, and final short form prospectus dated November 27, 2020, filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com.
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Appointment of Dr. Kelmendi, Assistant Professor of Psychiatry at Yale University and co-founder of the Yale Psychedelic Science Group, brings another experienced medical professional to Lobe’s advisory team.
Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Benjamin Kelmendi, MD, Assistant Professor of Psychiatry at Yale University School of Medicine, to its Scientific Advisory Board.
Philip Young, CEO and Director of Lobe stated, “We are extremely pleased to welcome Ben to our Scientific Advisory Board. Dr. Kelmendi will add significant relevant experience to the team as we move through preclinical studies into human clinical trials. We look forward to working with Dr. Kelmendi and the team at the Yale Psychedelic Science Group.”
Dr. Kelmendi is a board-certified psychiatrist and is an Assistant Professor in the Department of Psychiatry at the Yale University School of Medicine and is also a co-founder of the Yale Psychedelic Science Group. His primary clinical expertise is in post-traumatic stress disorder (“PTSD“), depression, obsessive-compulsive disease (“OCD“). He leads a research program focused on the therapeutic potential of psychedelic medicines, across a range of psychiatric diagnosis. He is currently investigating the effects of psilocybin on the neurocircuitry implicated in the development, maintenance, and treatment of patients with OCD. He is also exploring the effects of MDMA on brain activation and neural network organization in PTSD to understand the relationship between MDMA-induced neural changes and the acute cognitive and behavioral effects of the drug.
Benjamin Kelmendi, MD stated, “The re-emergence of psychedelic medicine as a respected area of research has undergone a protean trajectory. In the most recent revival of investigations into potential therapeutic benefits of long-maligned psychedelic substances, we are now revisiting past work in this area completely differently with a heightened sense of scientific responsibility, knowledge, and technology. I am excited by the renewed interest in the potential of psychedelic substances, both as therapeutic agents and as tools to provide insight into the human brain and mind’s inner workings. I look forward to working with the Advisory Board and the Lobe team as we all work together to ethically develop psychedelic therapies for mental illness.”
About Lobe Sciences Ltd.
Lobe is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.
For further information please contact:
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
Disclaimer for Forward Looking Statements
This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact included in this release, including statements regarding the future plans and objectives of the Company, research and development using psychedelic compounds, the development of innovative devices and delivery mechanisms to improve mental health and wellness, moving through preclinical studies to human clinical trials, and working with the team at the Yale Psychedelic Science Group, are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including changes to the regulatory environment; that the Company’s drug research and development activities may be unsuccessful; that drugs and medical devices produced by, or on behalf of, the Company, may not work in the manner intended or at all, and may subject the Company to product liability or other liability claims; that the Company may not be able to attain the Company’s corporate goals and objectives; and other risk factors detailed in the Company’s continuous disclosure filings from time to time, as available under the Company’s profile at www.sedar.com. As a result, the Company cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made only as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as expressly required by applicable Canadian securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/80963
News Provided by Newsfile via QuoteMedia
Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or ” Ayurcann “), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to unveil further details of its Phase 2 expansion plans.
Ayurcann has commenced trading on the Canadian Securities Exchange (” CSE “) on April 8, 2021 and subsequently announced a private placement of up to $500,000 (” Financing “), as per the Company’s press release dated April 12, 2021. The proceeds of the Financing are intended to be used to further pursue Phase 2 of the expansion of the production capacity of the Company’s Pickering facility.
Following the closing of the Financing, the Company expects to continue the Phase 2 expansion, which is intended to increase the extraction capacity of the facility by 50% from 200,000 kgs to 300,000 kgs of biomass on an annualized basis. Ayurcann has continued to consistently secure over 1,000 kgs of hemp biomass and 1,000 kgs of cannabis biomass on a bi-weekly basis through multiple suppliers at attractive prices, and the Company estimates the increased production and current inventory translates to potential revenue of approximately $1 million per month.
This supply schedule currently enables the Company to produce over 300 kgs of high-quality distillate on a monthly basis, which may be used for bulk wholesale sales, or to produce higher margin value-added cannabis 2.0 concentrate products such as vaporizing pens, topicals, and edibles for our B2B clients.
Igal Sudman, CEO of Ayurcann, commented, “We wish to thank our shareholders for their support as we’ve made our successful debut on the CSE. We believe this is an opportune time to showcase the progress that we’ve made over the last several years and to highlight the steps we’re taking to aggressively accelerate sales.” Mr. Sudman continued: “We believe that our current facility offers one of the larger extraction capacities among the Canadian LPs and completion of our Phase 2 expansion plans will allow us to service more customers, which, we believe, will help increase revenues.”
For further information, please contact:
Igal Sudman, Chairman and CEO
Ayurcann Holdings Corp.
About Ayurcann Holdings Corp.:
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is striving to become a partner of choice for leading Canadian cannabis brands by providing best-in-class, proprietary services including ethanol extraction, formulation, product development and custom manufacturing.
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company’s expansion plans and future production capacity. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.
Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company’s facilities, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, Further, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company’s business, financial condition and/or results of operations. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company’s forward-looking statements.
News Provided by GlobeNewswire via QuoteMedia